by Ethan A. Huff, Natural News:
The bipartisan Congressional committee currently investigating the secret dealings between the Obama administration and Big Pharma prior to the passage of the massive health care overhaul is set to release pertinent new details as to what these dealings entailed. In a recent memorandum, the committee unveils the names of some of the key figures involved with these secret negotiations, and promises to release even more shocking details in the coming weeks.
Addressed specifically to the Republican members of the Energy and Commerce Committee, the memo explains a little bit more about how the Pharmaceutical Manufacturers of America (PhRMA), a powerful lobbying group that represents the drug and biotechnology industries, colluded with the federal government to make the terms of Obamacare as favorable to drug companies as possible. Both the federal government and PhRMA secretly agreed to abide by certain undisclosed commitments to one another as part of the passage of the bill, the details of which largely remain hidden from public view.
Please follow SGT Report on Twitter & help share the message.